BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1946
+0.0064 (3.40%)
Aug 22, 2025, 3:36 PM EDT
BioLargo Revenue
BioLargo had revenue of $2.78M in the quarter ending June 30, 2025, a decrease of -44.62%. This brings the company's revenue in the last twelve months to $14.05M, down -16.43% year-over-year. In the year 2024, BioLargo had annual revenue of $17.78M with 45.37% growth.
Revenue (ttm)
14.05M
Revenue Growth
-16.43%
P/S Ratio
4.13
Revenue / Employee
334.57K
Employees
44
Market Cap
57.99M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
Dec 31, 2020 | 2.43M | 571.00K | 30.68% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 252.15M |
Panamera Holdings | 212.04K |
Chykingyoung Investment Development Holdings | 305.65K |
Rubber Leaf | 2.02M |
Cardinal Ethanol, LLC | 350.34M |
BioLargo News
- 9 days ago - BioLargo Reports Q2 2025 Operating and Financial Results - Accesswire
- 9 days ago - BioLargo Q2 2025 Earnings Results Webcast and Conference Call on Friday, August 15, 2025 - 11 AM Eastern Time - Accesswire
- 4 weeks ago - BioLargo Provides Review of 2025 Accomplishments and Insights for Coming Year - Accesswire
- 7 weeks ago - BioLargo Initiates Alpha Testing of Verralize's Portable PFAS Test Kit to Validate Performance for Future Commercialization - Accesswire
- 2 months ago - BioLargo Announces Results of 2025 Annual Stockholder Meeting - Accesswire
- 2 months ago - Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage - Accesswire
- 3 months ago - BioLargo Q1 2025 Earnings Results Webcast and Conference Call on Thursday, May 15, 2025 - 4:30 PM Eastern Time - Accesswire
- 3 months ago - BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements - Accesswire